Search all trials

Find therapies in clinical trials near you – page 20

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Neurodermatitis

Not recruiting

Investigational

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Registered drug

Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Salbutamol

Contact Research Centre

Multiple sclerosis

Not recruiting

Investigational

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational

Poland

Participants:18–64 years
Substances:Frexalimab

Contact Research Centre

Type 2 diabetes mellitus+2

Not recruiting

Registered drug

Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Semaglutide

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on Guselkumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Guselkumab

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Poland

Participants:0–17 years
Substances:Golimumab

Contact Research Centre

Rhinitis allergic

Not recruiting

Registered drug

Study of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Pemphigoid

Not recruiting

Registered drug

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Dupilumab

Contact Research Centre

Hidradenitis

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Bimekizumab

Contact Research Centre

Find therapies in clinical trials near you – page 20

339 trials match your criteria

Neurodermatitis

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Chronic obstructive pulmonary disease

Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Multiple sclerosis

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Type 2 diabetes mellitus+2

Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

Colitis ulcerative

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Crohn's disease

Study on Guselkumab for Patients with Moderate to Severe Crohn's Disease

Parkinson's disease

Study on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease

Multiple sclerosis relapse

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Colitis ulcerative

Study on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis

Rhinitis allergic

Study of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis

Pemphigoid

Study of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid

Hidradenitis

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.